TickerFactsScreenerDevelopers

REGENERON PHARMACEUTICALS, INC. (REGN) — Operating Income

Annual figures by fiscal year, from SEC filings.

2008: -$86.25M2009: -$74.10M2010: -$97.47M2011: -$205.16M2012: $457.71M2013: $743.05M2014: $823.92M2015: $1.25B2016: $1.33B2017: $2.08B2018: $2.53B2019: $2.21B2020: $3.58B2021: $8.95B2022: $4.74B2023: $4.05B2024: $3.99B2025: $3.58B$3.58B
2008Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025$3.58B-10.3%
2024$3.99B-1.4%
2023$4.05B-14.6%
2022$4.74B-47.0%
2021$8.95B+150.1%
2020$3.58B+61.9%
2019$2.21B-12.8%
2018$2.53B+21.9%
2017$2.08B+56.3%
2016$1.33B+6.3%
2015$1.25B+51.9%
2014$823.92M+10.9%
2013$743.05M+62.3%
2012$457.71M+323.1%
2011-$205.16M-110.5%
2010-$97.47M-31.5%
2009-$74.10M+14.1%
2008-$86.25M—